Interestingly, certain human Syn III gene (SYN3) polymorphisms associate with ADHD onset and influence the response to the most effective ADHD treatment, methylphenidate (MPH), a monoamine reuptake inhibitor which binds Syn III [4,10,11,12]. This evidence concerns the gene SYN3 and attention deficit-hyperactivity disorder.